Sistemik Hastalıklar ve Glokom

Bodh SA, Kumar V, Raina UK, et al. Inflammatory glaucoma. Oman Journal of Ophthalmology 2011;4:3. https://doi.org/10.4103/0974-620X.77655.

Pattabiraman PP, Rao PV. Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells. American Journal of Physiology-Cell Physiology 2010;298:C749. https://doi.org/10.1152/AJPCELL.00317.2009.

Siddique SS, Suelves AM, Baheti U, et al. Glaucoma and uveitis. Survey of Ophthalmology 2013;58:1–10. https://doi.org/10.1016/J.SURVOPHTHAL.2012.04.006.

Ebrahimiadib N, Berijani S, Ghahari M, et al. Ankylosing Spondylitis. Journal of Ophthalmic and Vision Research 2021;16:462–9. https://doi.org/10.18502/JOVR.V16I3.9440.

Paroli MP, Del Giudice E, Giovannetti F, et al. Management Strategies of Juvenile Idiopathic Arthritis-Associated Chronic Anterior Uveitis: Current Perspectives. Clinical Ophthalmology 2022;16:1665. https://doi.org/10.2147/OPTH.S342717.

Merayo-Lloves J, Power WJ, Rodriguez A, et al. Secondary glaucoma in patients with uveitis. Ophthalmologica 1999;213:300–4. https://doi.org/10.1159/000027443.

Stroh IG, Moradi A, Burkholder BM, et al. Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma in Juvenile Idiopathic Arthritis-associated Uveitis. Ocular Immunology and Inflammation, 2017;25:503–12. https://doi.org/10.3109/09273948.2016.1142573.

Foster CS, Havrlikova K, Baltatzis S, et al. Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Acta Ophthalmologica Scandinavica 2000;78:576–9. https://doi.org/10.1034/J.1600-0420.2000.078005576.X.

Obenauf CD, Shaw HE, Sydnor CF, et al. Sarcoidosis and its ophthalmic manifestations. American Journal of Ophthalmology 1978;86:648–55. https://doi.org/10.1016/0002-9394(78)90184-8.

Pasadhika S, Rosenbaum JT. Ocular Sarcoidosis. Clinics in Chest Medicine 2015;36:669. https://doi.org/10.1016/J.CCM.2015.08.009.

Elgin U, Berker N, Batman A. Incidence of secondary glaucoma in behcet disease. Journal of Glaucoma 2004;13:441–4. https://doi.org/10.1097/00061198-200412000-00002.

Belkhadir K, Boutimzine N, Tachfouti S, et al. Uveitic glaucoma in Behçet’s disease: When everything gets complicated. Journal Français d'Ophtalmologie 2020;43:635–41. https://doi.org/10.1016/J.JFO.2019.12.005.

Aldaas K, Challa P, Weber DJ, et al. Infections and glaucoma. Survey of Ophthalmology 2022;67:637–58. https://doi.org/10.1016/J.SURVOPHTHAL.2021.08.009.

Hogan MJ, Kimura SJ, Thygeson P. Pathology of Herpes Simplex Kerato-Iritis. Transactions of the American Ophthalmological Society 1963;61:75.

Townsend WM, Kaufman HE. Pathogenesis of glaucoma and endothelial changes in herpetic kerato-uveitis in rabbits. American Journal of Ophthalmology 1971;71:904–10. https://doi.org/10.1016/0002-9394(71)90265-0.

Jones R, Pasquale LR, Pavan-Langston D. Herpes simplex virus: an important etiology for secondary glaucoma. International Ophthalmology Clinics 2007;47:99–107. https://doi.org/10.1097/IIO.0B013E3180377632.

Davis AR, Sheppard J. Herpes Zoster Ophthalmicus Review and Prevention. Eye Contact Lens 2019;45:286–91. https://doi.org/10.1097/ICL.0000000000000591.

Journal O, Kalogeropoulos CD, Bassukas ID, et al. Eye and Periocular Skin Involvement in Herpes Zoster Infection. Medical hypothesis discovery and innovation in ophthalmology 2015;4:142. PMID: 27800502; PMCID: PMC5087099.

Nigam P, Kumar A, Kapoor KK, et al. Clinical profile of herpes zoster ophthalmicus. Journal of Indian Medical Association 1991;89:117–9.

Thean JHJ, Hall AJH, Stawell RJ. Uveitis in Herpes zoster ophthalmicus. Clinical & Experimental Ophthalmology 2001;29:406–10. https://doi.org/10.1046/J.1442-9071.2001.D01-29.X.

Loewenstein A, Geyer O, Hourvitz D, et al. Bilateral simultaneous spontaneous acute angle closure glaucoma in a herpes zoster patient. British Journal of Ophthalmology 1991;75:510. https://doi.org/10.1136/BJO.75.8.510.

Ceccato F, Boscaro M. Cushing’s Syndrome: Screening and Diagnosis. High Blood Pressure & Cardiovascular Prevention 2016;23:209–15. https://doi.org/10.1007/S40292-016-0153-4.

Jonas JB, Huschle O, Koniszewski G, et al. Intraocular pressure in patients with Cushing’s disease. Graefe's Archive for Clinical and Experimental Ophthalmology 1990;228:407–9. https://doi.org/10.1007/BF00927251.

Ma Y, Chen Z, Ma Z, et al. Increased Risk of Ocular Hypertension in Patients With Cushing’s Disease. Journal of Glaucoma 2022;31:941–6. https://doi.org/10.1097/IJG.0000000000002113.

Tsushima Y, Munshi LB, Taneja C, et al. CUSHING DISEASE MASQUERADING AS GLAUCOMA. AACE Clinical Case Reports 2019;5:e290. https://doi.org/10.4158/ACCR-2019-0097.

Bahn RS. Graves’ ophthalmopathy. The New England Journal of Medicine 2010;362:726–38. https://doi.org/10.1056/NEJMRA0905750.

Betzler BK, Young SM, Sundar G. Intraocular Pressure and Glaucoma in Thyroid Eye Disease. Ophthalmic Plastic & Reconstructive Surgery 2022;38:219–25. https://doi.org/10.1097/IOP.0000000000002049.

Takahashi Y, Nakamura Y, Ichinose A, et al. Intraocular pressure change with eye positions before and after orbital decompression for thyroid eye disease. Ophthalmic Plastic & Reconstructive Surgery 2014;30:47–50. https://doi.org/10.1097/IOP.0000000000000007.

Choi CJ, Oropesa S, Callahan AB, et al. Patterns of visual field changes in thyroid eye disease. Orbit 2017;36:201–7. https://doi.org/10.1080/01676830.2017.1314510.

Bigger JF. Glaucoma with elevated episcleral venous pressure. Southern Medical Journal 1975;68:1444–8. https://doi.org/10.1097/00007611-197511000-00026.

Chaudhry IA, Elkhamry SM, Al-Rashed W, et al. Carotid Cavernous Fistula: Ophthalmological Implications. Middle East African Journal of Ophthalmology 2009;16:57. https://doi.org/10.4103/0974-9233.53862.

Razeghinejad R, Lin MM, Lee D, et al. Pathophysiology and management of glaucoma and ocular hypertension related to trauma. Survey of Ophthalmology 2020;65:530–47. https://doi.org/10.1016/J.SURVOPHTHAL.2020.02.003.

Preechawat P, Narmkerd P, Jiarakongmun P, et al. Dural carotid cavernous sinus fistula: ocular characteristics, endovascular management and clinical outcome. Journal of the Medical Association of Thailand 2008;91:852–8.

Henderson AD, Miller NR. Carotid-cavernous fistula: current concepts in aetiology, investigation, and management. Eye 2018;32:164. https://doi.org/10.1038/EYE.2017.240.

Miller NR. Diagnosis and management of dural carotid-cavernous sinus fistulas. Neurosurgical Focus 2007;23:E13. https://doi.org/10.3171/FOC-07/11/E13.

Calafiore S, Perdicchi A, Scuderi G, et al. Glaucoma Management in Carotid Cavernous Fistula. Case Reports in Ophthalmology 2016;7:296. https://doi.org/10.1159/000446151.

Ishijima K, Kashiwagi K, Nakano K, et al. Ocular manifestations and prognosis of secondary glaucoma in patients with carotid-cavernous fistula. Japanese Journal of Ophthalmology 2003;47:603–8. https://doi.org/10.1016/j.jjo.2003.08.002.

Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology 2000;107:1287–93. https://doi.org/10.1016/S0161-6420(00)00138-X.

Dascalu AM, Stana D, Nicolae VA, et al. Association between vascular comorbidity and glaucoma progression: A four-year observational study. Experimental and Therapeutic Medicine 2021;21. https://doi.org/10.3892/ETM.2021.9714.

Karaconji T, Zagora S, Grigg JR. Approach to childhood glaucoma: A review. Clinical Experimental Ophthalmology 2022;50:232–46. https://doi.org/10.1111/CEO.14039.

Alward WLM. Axenfeld-Rieger syndrome in the age of molecular genetics. American Journal of Ophthalmology 2000;130:107–15. https://doi.org/10.1016/S0002-9394(00)00525-0.

Lewis CJ, Hedberg-Buenz A, DeLuca AP, et al. Primary congenital and developmental glaucomas. Human Molecular Genetics 2017;26:R28. https://doi.org/10.1093/HMG/DDX205.

Edward DP, Morales J, Bouhenni RA, et al. Congenital ectropion uvea and mechanisms of glaucoma in neurofibromatosis type 1: new insights. Ophthalmology 2012;119:1485–94. https://doi.org/10.1016/J.OPHTHA.2012.01.027.

Tzili N, El Orch H, Bencherifa F, et al. Le glaucome congénitale et la neurofibromatose type 1. The Pan African Medical Journal 2015;21:138. https://doi.org/10.11604/PAMJ.2015.21.56.6794.

Roberti G, Oddone F, Agnifili L, et al. Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management. Survey of Ophthalmology 2020;65:458–72. https://doi.org/10.1016/J.SURVOPHTHAL.2020.01.002.

Razeghinejad MR, Pro MJ, Katz LJ. Non-steroidal drug-induced glaucoma. Eye 2011;25:971. https://doi.org/10.1038/EYE.2011.128.

Krasińska B, Karolczak-Kulesza M, Krasiński Z, et al. Effects of the time of antihypertensive drugs administration on the stage of primary open-angle glaucoma in patients with arterial hypertension. Blood Pressure 2012;21:240–8. https://doi.org/10.3109/08037051.2012.666423.